Skip to content
healthcare.dev
Get a free key

Erythromycin Ethylsuccinate

NDC 75834-294, Erythromycin Ethylsuccinate, suspension, from Nivagen Pharmaceuticals, Inc..

Product NDC
75834-294
Status
Listed
Labeler
Nivagen Pharmaceuticals, Inc.
Dosage form
SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA216212
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/75834-294 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ERYTHROMYCIN ETHYLSUCCINATE400 mg/5mL

Pharmacologic classes

Decreased Sebaceous Gland Activity [PE]; Macrolide Antimicrobial [EPC]; Macrolide [EPC]; Macrolides [CS]

Package NDCNDC-11Package
75834-294-0175834029401100 mL in 1 BOTTLE (75834-294-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/46f74c4f-10fc-44cf-aec4-d113f49149bc

  • NADAC price for package 75834029401

    GET /v1/drugs/nadac/75834029401

Use it

Look up 75834-294 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/75834-294 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 75834-294. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.